author-photo

Andrew E. Tee

University of New South Wales

31

Papers

931

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma.

2021 Molecular Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN‐amplified neuroblastoma

2020 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Abstract 5721: The super-enhancer driven long noncoding RNA lncNB promotes neuroblastoma tumorigenesis

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (30)
Abstract 5209: Efficacious targeting of TERT oncogene rearrangement with BET bromodomain inhibitor and proteasome inhibitor combination therapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-080: The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 2453: Eradication of neuroblastoma by suppressing the expression of a single noncoding RNA

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
NCYM is upregulated by lncUSMycN and modulates N-Myc expression

2016 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (15)
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (11)